| Autor: |
Świeczkowski-Feiz S; Department of General, Endocrine and Vascular Surgery, University Clinical Center of the Medical University of Warsaw, Poland., Toutounchi S; Department of General, Endocrine and Vascular Surgery, University Clinical Center of the Medical University of Warsaw, Poland., Kaszczewski P; Department of General, Endocrine and Vascular Surgery, University Clinical Center of the Medical University of Warsaw, Poland., Krajewska E; Department of General, Endocrine and Vascular Surgery, University Clinical Center of the Medical University of Warsaw, Poland., Celejewski K; Department of General, Endocrine and Vascular Surgery, University Clinical Center of the Medical University of Warsaw, Poland., Gelo R; 2nd Clinic of Anesthesiology and Intensive Care, University Clinical Center of the Medical University of Warsaw, Poland., Pogorzelski R; Department of General, Endocrine and Vascular Surgery, University Clinical Center of the Medical University of Warsaw, Poland., Gałązka Z; Department of General, Endocrine and Vascular Surgery, University Clinical Center of the Medical University of Warsaw, Poland. |
| Abstrakt: |
<b>Introduction:</b> Adrenal hemorrhage (AH) is a very rare and potentially life-threatening disease which may be secondary to trauma or of non-traumatic etiology.<b>Aim:</b> The aim of the study was to present the characteristics and management of adrenal hemorrhage and show that adrenal hemorrhage is more common than expected and that the clinical symptoms are not specific.<b>Materials and methods:</b> This retrospective study involved 199 patients with postoperative diagnosis of adrenal hemorrhage.<b>Discussion:</b> The factors identified as potential causes of adrenal hemorrhage are adrenocortical carcinoma, pheochromocytoma, and adrenal adenoma. The study group included 199 patients with postoperative diagnosis of AH. It showed that all patients with postoperative diagnosis had pheochromocytoma (n = 54), adrenal adenoma (n = 68), or adenocarcinoma (n = 17). If we look more careful at the results, we can find only 30% of patients (n = 39) with preoperative diagnosis of AH. This group of 39 patients was prepared for expedited surgery. In this group of patients, the preoperative diagnosis of AH was pheochromocytoma 28% (n = 11), adenocarcinoma (n = 4), and adrenal adenoma (n = 9).<b>Conclusions:</b> Bleeding into adrenal tumors is still an insufficiently understood topic due to its unpredictability and, as can be seen in our material, of varying severity. Out of 199 patients, only 30% (n = 39) were prepared for surgery with a preoperative diagnosis of AH; most of them had pheochromocytoma. We suggest that is very important to prepare patients for surgery with a preoperative diagnosis of AH using α-adrenoreceptor antagonists. Prolongation of the diagnostic process (time between the imaging examination and the surgery) may result in the disease progressing and adrenal bleeding. |
